Filing Flows

Filing Flows › Apyx Medical (APYX) › Next earnings date

Apyx Medical (APYX) earnings: beat the estimate

Apyx Medical (APYX) reported on Nov 5, 2026 and beat the EPS estimate: −$0.04 against −$0.09 (+57.1%). Revenue was $14.0M for Q3 2026, +9% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+57.1% vs estimate
Beat rate100%

The last report

Apyx Medical reported revenue of $14.0M for the third quarter 2026 (+9% Y/Y), net loss $1.8M. How it makes money → · Every quarter →

Apyx Medical: EPS against the estimate, last 5 reportsApyx Medical: EPS against the estimate, last 5 reportsEstimateReported−$0.10−$0.05Nov 25−$0.06−$0.03Mar 26−$0.11−$0.05May 26−$0.08−$0.07Aug 26−$0.09−$0.04Nov 26
Latest (Nov 26): Estimate −$0.09, Reported −$0.04.

Apyx Medical's latest quarter

Apyx Medical, Q3 2026: revenue $14.0M (+9% year over year), operating margin -4.1%, net loss $1.8M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.

Questions

Did Apyx Medical beat earnings?

Apyx Medical (APYX) reported on Nov 5, 2026 and beat the EPS estimate: −$0.04 against −$0.09 (+57.1%).

When does APYX report earnings?

The next date is not set yet.

Does Apyx Medical usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.